Feedback / Questions
ALTA-3263 - Alterome Therap
https://www.businesswire.com/news/home/20250310531954/en/Alterome-Doses-First-Patient-in-Phase-1-Study-of-ALTA3263-a-Novel-Pan-KRAS-Dual-ONOFF-Inhibitor-in-Advanced-Solid-Tumors/
Mar 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next